OAM
AXGN icon

Oppenheimer Asset Management’s Axogen AXGN Stock Holding History

Oppenheimer Asset Management’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,762
Closed -$77K – 1600
2018
Q4 		$77K Buy
+3,762
New +$118K ﹤0.01% 1241

Other funds holding AXGN

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Oppenheimer Asset Management's AXGN Position: Q1 2019 in Review

Oppenheimer Asset Management sold out of Axogen (AXGN) in Q1 2019, closing a stake of 3,762 shares — an estimated $77K sold.

Oppenheimer Asset Management first reported a position in AXGN in Q4 2018 and held it in 1 quarter. The position peaked at $77K in Q4 2018. 141 funds tracked by Wall St. Rank hold AXGN as of Q1 2019.

  • Oppenheimer Asset Management reported no remaining Axogen position as of Q1 2019 after selling out during the quarter.
  • Oppenheimer Asset Management sold 3,762 Axogen shares in Q1 2019, an estimated $77K.
  • Oppenheimer Asset Management first reported a position in Axogen in Q4 2018 and held it in 1 quarter.
  • Oppenheimer Asset Management's Axogen position peaked at $77K in Q4 2018.
  • 141 funds tracked by Wall St. Rank held Axogen as of Q1 2019.

Based on Oppenheimer Asset Management's 13F filing for Q1 2019, filed 24 Apr 2019.